View Post

September 1, 2015

Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.

In by Heather DelCarpini

Comparing Glucommander IV to usual care for treatment of diabetic ketoacidosis. Diabetes in Control interviews Dr. Joseph Aloi.

View Post

August 1, 2015

Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.

In by Heather DelCarpini

Use of integrated insulin algorithms for cardiovascular surgery patients, including reasons for replacing Monarch Medical Technologies’ EndoTool with Glytec’s Glucommander. MD Magazine interviews Dr. Valerie Garrett.

View Post

July 1, 2015

How eGMS enables subcutaneous basal bolus insulin therapy and overcomes difficulties of meal-to-meal dosing adjustments. MD Magazine interviews Dr. Jagdeesh Ullal.

In by Heather DelCarpini

How eGMS enables subcutaneous basal bolus insulin therapy and overcomes difficulties of meal-to-meal dosing adjustments. MD Magazine interviews Dr. Jagdeesh Ullal.

View Post

May 1, 2015

Use of Glucommander to prevent medication errors involving insulin. Diabetes in Control interviews Dr. Joseph Aloi.

In by Heather DelCarpini

Use of Glucommander to prevent medication errors involving insulin. Diabetes in Control interviews Dr. Joseph Aloi.

View Post

January 1, 2015

How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.

In by Heather DelCarpini

How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.